Lung cancer in Japan

Analysis of lung cancer registry cases resected in 2004

Noriyoshi Sawabata, Yoshitaka Fujii, Hisao Asamura, Hiroaki Nomori, Yoichi Nakanishi, Kenji Eguchi, Masaki Mori, Meinoshin Okumura, Etsuo Miyaoka, Kohei Yokoi

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

抄録

The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7,369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295. 6,295). 82.0% and 82.0%; IB (n = 2,788. 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899. 648), 48.6% and 46.4%; IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407.90). 41.6% and 40.3%; and IV (n = 131,256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5.611,4,978), 85.9% and 86.8%; IB (n = 2.398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1,354, 1,804), 41.0% and 40.9%; IIIB (n = 799,106), 36.7% and 27.8%; and IV (n = 188,434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9%; squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3%; small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

元の言語英語
ページ(範囲)875-888
ページ数14
ジャーナルJapanese Journal of Lung Cancer
50
発行部数7
DOI
出版物ステータス出版済み - 12 1 2010

Fingerprint

Registries
Lung Neoplasms
Japan
Adenosquamous Carcinoma
Large Cell Carcinoma
Small Cell Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Thorax

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine

これを引用

Sawabata, N., Fujii, Y., Asamura, H., Nomori, H., Nakanishi, Y., Eguchi, K., ... Yokoi, K. (2010). Lung cancer in Japan: Analysis of lung cancer registry cases resected in 2004. Japanese Journal of Lung Cancer, 50(7), 875-888. https://doi.org/10.2482/haigan.50.875

Lung cancer in Japan : Analysis of lung cancer registry cases resected in 2004. / Sawabata, Noriyoshi; Fujii, Yoshitaka; Asamura, Hisao; Nomori, Hiroaki; Nakanishi, Yoichi; Eguchi, Kenji; Mori, Masaki; Okumura, Meinoshin; Miyaoka, Etsuo; Yokoi, Kohei.

:: Japanese Journal of Lung Cancer, 巻 50, 番号 7, 01.12.2010, p. 875-888.

研究成果: ジャーナルへの寄稿記事

Sawabata, N, Fujii, Y, Asamura, H, Nomori, H, Nakanishi, Y, Eguchi, K, Mori, M, Okumura, M, Miyaoka, E & Yokoi, K 2010, 'Lung cancer in Japan: Analysis of lung cancer registry cases resected in 2004', Japanese Journal of Lung Cancer, 巻. 50, 番号 7, pp. 875-888. https://doi.org/10.2482/haigan.50.875
Sawabata N, Fujii Y, Asamura H, Nomori H, Nakanishi Y, Eguchi K その他. Lung cancer in Japan: Analysis of lung cancer registry cases resected in 2004. Japanese Journal of Lung Cancer. 2010 12 1;50(7):875-888. https://doi.org/10.2482/haigan.50.875
Sawabata, Noriyoshi ; Fujii, Yoshitaka ; Asamura, Hisao ; Nomori, Hiroaki ; Nakanishi, Yoichi ; Eguchi, Kenji ; Mori, Masaki ; Okumura, Meinoshin ; Miyaoka, Etsuo ; Yokoi, Kohei. / Lung cancer in Japan : Analysis of lung cancer registry cases resected in 2004. :: Japanese Journal of Lung Cancer. 2010 ; 巻 50, 番号 7. pp. 875-888.
@article{363ef58b56dd4be99ef454f29057d45b,
title = "Lung cancer in Japan: Analysis of lung cancer registry cases resected in 2004",
abstract = "The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6{\%}, while the 5-year survival rate in males (n = 7,369) was 63.0{\%} and 80.9{\%} in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295. 6,295). 82.0{\%} and 82.0{\%}; IB (n = 2,788. 2,339), 63.4{\%} and 66.1{\%}, IIA (n = 203, 819), 55.4{\%} and 54.5{\%}; IIB (n = 899. 648), 48.6{\%} and 46.4{\%}; IIIA (n = 940, 1,216), 43.3{\%} and 42.8{\%}; IIIB (n = 407.90). 41.6{\%} and 40.3{\%}; and IV (n = 131,256), 29.1{\%} and 31.4{\%}, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5.611,4,978), 85.9{\%} and 86.8{\%}; IB (n = 2.398, 2,552), 69.3{\%} and 73.9{\%}; IIA (n = 336, 941), 60.9{\%} and 61.6{\%}; IIB (n = 977, 848), 51.1{\%} and 49.8{\%}; IIIA (n = 1,354, 1,804), 41.0{\%} and 40.9{\%}; IIIB (n = 799,106), 36.7{\%} and 27.8{\%}; and IV (n = 188,434), 27.8{\%} and 27.9{\%}, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9{\%}; squamous cell carcinoma, 59.1{\%}; large cell carcinoma, 53.3{\%}; small cell carcinoma, 52.6{\%}; and adenosquamous cell carcinoma, 50.8{\%}. Operative death occurred in 48 cases (0.4{\%}) and hospital death in 46 (0.4{\%}).",
author = "Noriyoshi Sawabata and Yoshitaka Fujii and Hisao Asamura and Hiroaki Nomori and Yoichi Nakanishi and Kenji Eguchi and Masaki Mori and Meinoshin Okumura and Etsuo Miyaoka and Kohei Yokoi",
year = "2010",
month = "12",
day = "1",
doi = "10.2482/haigan.50.875",
language = "English",
volume = "50",
pages = "875--888",
journal = "Japanese Journal of Lung Cancer",
issn = "0386-9628",
publisher = "Japan Lung Cancer Society",
number = "7",

}

TY - JOUR

T1 - Lung cancer in Japan

T2 - Analysis of lung cancer registry cases resected in 2004

AU - Sawabata, Noriyoshi

AU - Fujii, Yoshitaka

AU - Asamura, Hisao

AU - Nomori, Hiroaki

AU - Nakanishi, Yoichi

AU - Eguchi, Kenji

AU - Mori, Masaki

AU - Okumura, Meinoshin

AU - Miyaoka, Etsuo

AU - Yokoi, Kohei

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7,369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295. 6,295). 82.0% and 82.0%; IB (n = 2,788. 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899. 648), 48.6% and 46.4%; IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407.90). 41.6% and 40.3%; and IV (n = 131,256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5.611,4,978), 85.9% and 86.8%; IB (n = 2.398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1,354, 1,804), 41.0% and 40.9%; IIIB (n = 799,106), 36.7% and 27.8%; and IV (n = 188,434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9%; squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3%; small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

AB - The Japan Lung Cancer Society, Japanese Association for Chest Surgery, and Japanese Respiratory Society jointly established the Japanese Joint Committee for Lung Cancer Registration. In 2010, analyses of 11,663 cases of lung cancer that underwent surgical resection in 2004 were performed, then the findings were registered and collected for analysis by the committee. The survival rate for all cases was 69.6%, while the 5-year survival rate in males (n = 7,369) was 63.0% and 80.9% in females (n = 4,294). The 5-year survival rates by c-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 6,295. 6,295). 82.0% and 82.0%; IB (n = 2,788. 2,339), 63.4% and 66.1%, IIA (n = 203, 819), 55.4% and 54.5%; IIB (n = 899. 648), 48.6% and 46.4%; IIIA (n = 940, 1,216), 43.3% and 42.8%; IIIB (n = 407.90). 41.6% and 40.3%; and IV (n = 131,256), 29.1% and 31.4%, respectively. The 5-year survival rates by p-stage (UICC Ver. 6 and Ver. 7) were as follow: IA (n = 5.611,4,978), 85.9% and 86.8%; IB (n = 2.398, 2,552), 69.3% and 73.9%; IIA (n = 336, 941), 60.9% and 61.6%; IIB (n = 977, 848), 51.1% and 49.8%; IIIA (n = 1,354, 1,804), 41.0% and 40.9%; IIIB (n = 799,106), 36.7% and 27.8%; and IV (n = 188,434), 27.8% and 27.9%, respectively. The 5-year survival rates by histological type were as follow: adenocarcinoma, 74.9%; squamous cell carcinoma, 59.1%; large cell carcinoma, 53.3%; small cell carcinoma, 52.6%; and adenosquamous cell carcinoma, 50.8%. Operative death occurred in 48 cases (0.4%) and hospital death in 46 (0.4%).

UR - http://www.scopus.com/inward/record.url?scp=79952566152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952566152&partnerID=8YFLogxK

U2 - 10.2482/haigan.50.875

DO - 10.2482/haigan.50.875

M3 - Article

VL - 50

SP - 875

EP - 888

JO - Japanese Journal of Lung Cancer

JF - Japanese Journal of Lung Cancer

SN - 0386-9628

IS - 7

ER -